The directory is taking shape. Reviewed clinic profiles are coming soon.
Regulation

Investigational new drug application

Also known as: IND

A submission to FDA supporting investigation of a drug or biological product in people under the applicable rules.

Source-checked educational compilation · Not independently clinically reviewed

What this means in a clinic conversation

An IND concerns investigational use. It should not be described as marketing approval; ask about the specific study or access arrangement rather than relying on the acronym.

A question to bring

Which investigational arrangement covers this product and use, and who is the sponsor?

Open the visit checklist →

Related and commonly confused terms

Use the term in context

Sources and editorial context

This definition was compiled from the sources below and has not received independent clinical review. It supports understanding and consultation preparation.

  1. IND Applications for Clinical Investigations: Overview · U.S. Food and Drug AdministrationReference checked 2026-10-02
Back to the A–Z glossary →